| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1039302967 |
| P356 | DOI | 10.1038/373339A0 |
| P698 | PubMed publication ID | 7830767 |
| P2093 | author name string | Rosenthal A | |
| Poulsen K | |||
| Valverde J | |||
| Hefti F | |||
| Beck KD | |||
| Moffat B | |||
| Alexi T | |||
| Vandlen RA | |||
| P2860 | cites work | GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons | Q24336322 |
| Ciliary neurotrophic factor prevents retrograde neuronal death in the adult central nervous system | Q36161670 | ||
| Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo | Q36406386 | ||
| Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain | Q41100334 | ||
| TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons | Q41431348 | ||
| Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats | Q41439445 | ||
| Regional and cell-specific expression of GDNF in rat brain | Q41510303 | ||
| Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo | Q41512760 | ||
| Effects of chronic basic fibroblast growth factor administration to rats with partial fimbrial transections on presynaptic cholinergic parameters and muscarinic receptors in the hippocampus: comparison with nerve growth factor | Q42506735 | ||
| Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections | Q42525515 | ||
| Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section | Q44602903 | ||
| Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture | Q46045108 | ||
| Influences of neurotrophins on mammalian motoneurons in vivo | Q46111488 | ||
| Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. | Q46172163 | ||
| bFGF promotes the survival of entorhinal layer II neurons after perforant path axotomy | Q46370637 | ||
| Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death | Q46535566 | ||
| Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures | Q48225542 | ||
| Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo | Q48328793 | ||
| Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. | Q48965485 | ||
| Members of several gene families influence survival of rat motoneurons in vitro and in vivo. | Q52220975 | ||
| Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. | Q52241335 | ||
| Basic fibroblast growth factor in the hypoglossal system: specific retrograde transport, trophic, and lesion-related responses | Q67463638 | ||
| P433 | issue | 6512 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| P304 | page(s) | 339-341 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain | |
| P478 | volume | 373 |
| Q40980458 | A commentary on glial cell line-derived neurotrophic factor (GDNF). From a glial secreted molecule to gene therapy |
| Q41049950 | A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. |
| Q33904739 | A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11 |
| Q40963111 | Absence of the dopamine D2 receptor leads to a decreased expression of GDNF and NT-4 mRNAs in restricted brain areas |
| Q34434662 | Adenoviral vector-mediated delivery of glial cell line-derived neurotrophic factor provides neuroprotection in the aged parkinsonian rat. |
| Q40911927 | Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents ischemic brain injury after transient middle cerebral artery occlusion in rats |
| Q37877223 | Adult neurogenesis and brain regeneration in zebrafish |
| Q41096467 | Amelioration of brain edema by topical application of glial cell line-derived neurotrophic factor in reperfused rat brain |
| Q41107033 | An Acid-Treatment Method for the Enhanced Detection of GDNF in Biological Samples |
| Q35765360 | Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons |
| Q34031071 | Approach to ex vivo gene therapy in the treatment of Parkinson's disease |
| Q33939090 | Astrocyte line SVG-TH grafted in a rat model of Parkinson's disease |
| Q39704010 | Astrocytic endogenous glial cell derived neurotrophic factor production is enhanced by bone marrow stromal cell transplantation in the ischemic boundary zone after stroke in adult rats |
| Q41045671 | Basal ganglia: new therapeutic approaches to Parkinson's disease |
| Q40683212 | Bimodal upregulation of glial cell line-derived neurotrophic factor (GDNF) in the neonatal rat brain following ischemic/hypoxic injury |
| Q41531457 | Bone morphogenetic proteins in the nervous system |
| Q41096397 | Bone morphogenetic proteins: neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells |
| Q54411096 | Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells. |
| Q33954437 | Cabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor. |
| Q36501709 | Changes in Glial cell line-derived neurotrophic factor expression in the rostral and caudal stumps of the transected adult rat spinal cord |
| Q34383378 | Characterization of a multicomponent receptor for GDNF. |
| Q30713688 | Characterization of a promoter for the human glial cell line-derived neurotrophic factor gene |
| Q48102803 | Characterization of dopaminergic midbrain neurons in a DBH:BDNF transgenic mouse |
| Q37507768 | Cistanche tubulosa Protects Dopaminergic Neurons through Regulation of Apoptosis and Glial Cell-Derived Neurotrophic Factor: in vivo and in vitro |
| Q41082876 | Cloning and characterization of murine glial cell-derived neurotrophic factor inducible transcription factor (MGIF). |
| Q32151361 | Cloning and structural organization of the gene encoding the mouse glial cell line-derived neurotrophic factor, GDNF. |
| Q64787878 | Co-grafts of muscle cells and mesencephalic tissue into hemiparkinsonian rats: behavioral and histochemical effects |
| Q39346828 | Cografting of carotid body cells improves the long-term survival, fiber outgrowth and functional effects of grafted dopaminergic neurons. |
| Q41110376 | Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. |
| Q40583619 | Complications of a trophic xenotransplant approach in parkinsonian monkeys |
| Q50069089 | Constitutive Ret signaling leads to long-lasting expression of amphetamine-induced place conditioning via elevation of mesolimbic dopamine |
| Q40464992 | Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease. |
| Q38897951 | Controlled release of glial cell line-derived neurotrophic factor from poly(ε-caprolactone) microspheres. |
| Q39815602 | Culture of motor neurons from newborn rat spinal cord |
| Q36906840 | Deep brain stimulation and chemical neuromodulation: current use and perspectives for the future. |
| Q24317594 | Defects in enteric innervation and kidney development in mice lacking GDNF |
| Q28512489 | Defects in sensory and autonomic ganglia and absence of locus coeruleus in mice deficient for the homeobox gene Phox2a |
| Q52166629 | Developmental cell death in dopaminergic neurons of the substantia nigra of mice. |
| Q40964379 | Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons |
| Q40905804 | Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat. |
| Q40945102 | Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons |
| Q40762850 | Differential regulation of glial cell line-derived neurotrophic factor (GDNF) mRNA expression during hypoxia and reoxygenation in astrocytes isolated from stroke-prone spontaneously hypertensive rats |
| Q40958612 | Differential role of GDNF and NGF in the maintenance of two TTX-resistant sodium channels in adult DRG neurons |
| Q40938335 | Differential signaling of glial cell line-derived neurothrophic factor and brain-derived neurotrophic factor in cultured ventral mesencephalic neurons |
| Q41522446 | Differentiation and apoptosis of human germinal center B-lymphocytes |
| Q39611850 | Differentiation and tropic/trophic effects of exogenous neural precursors in the adult spinal cord |
| Q40796014 | Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors. |
| Q28187904 | Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease |
| Q33542013 | Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases |
| Q31949243 | Dopamine increases glial cell line-derived neurotrophic factor in human fetal astrocytes |
| Q48810893 | Dopaminergic innervation of striatal grafts placed into different sites of normal striatum: differences in the tyrosine hydroxylase immunoreactive growth pattern |
| Q40710921 | Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease |
| Q40654725 | Dose-dependent rescue of axotomized rat retinal ganglion cells by adenovirus-mediated expression of glial cell-line derived neurotrophic factor in vivo. |
| Q40619846 | Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neuroche |
| Q37158784 | Effects of electroacupuncture on depression and the production of glial cell line-derived neurotrophic factor compared with fluoxetine: a randomized controlled pilot study |
| Q37162058 | Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures |
| Q39138879 | Effects of glial cell line-derived neurotrophic factor on microRNA expression in a 6-hydroxydopamine-injured dopaminergic cell line |
| Q40249567 | Effects of repeated morphine on locomotion, place preference and dopamine in heterozygous glial cell line-derived neurotrophic factor knockout mice. |
| Q36048615 | Effects of striatal transplantation of cells transfected with GDNF gene without pre- and pro-regions in mouse model of Parkinson's disease |
| Q47397177 | Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra |
| Q36580572 | Emerging drugs for Parkinson's disease |
| Q34120723 | Encapsulated neural transplants |
| Q40624383 | Enhancement of tyrosine hydroxylase phosphorylation and activity by glial cell line-derived neurotrophic factor |
| Q28139368 | Enovin, a member of the glial cell-line-derived neurotrophic factor (GDNF) family with growth promoting activity on neuronal cells. Existence and tissue-specific expression of different splice variants |
| Q35892693 | Ethanol and nicotine interaction within the posterior ventral tegmental area in male and female alcohol-preferring rats: evidence of synergy and differential gene activation in the nucleus accumbens shell |
| Q33714108 | Etiology of Parkinson's disease |
| Q37462819 | Excessive alcohol consumption is blocked by glial cell line-derived neurotrophic factor |
| Q47121220 | Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease |
| Q24682581 | Expression and regulation of GFRalpha3, a glial cell line-derived neurotrophic factor family receptor |
| Q40935460 | Expression of GDNF and GDNFR-alpha mRNAs in muscles of patients with motor neuron diseases |
| Q33207163 | Expression of GDNF and GFR alpha 1 in mouse taste bud cells |
| Q41036193 | Expression of GDNF family receptor components during development: implications in the mechanisms of interaction. |
| Q40972496 | Expression of GDNF receptor (RET and GDNFR-alpha) mRNAs in the spinal cord of patients with amyotrophic lateral sclerosis |
| Q45764657 | Expression of L1 in primary astrocytes via a defective herpes simplex virus vector promotes neurite outgrowth and neural cell migration |
| Q40408628 | Expression of glial cell line-derived neurotrophic factor (GDNF) and GDNF family receptor alpha1 in mouse taste bud cells after denervation |
| Q40916994 | Expression of glial cell line-derived neurotrophic factor in the brain and cerebrospinal fluid of the developing rat. |
| Q40763433 | Expression of glial cell line-derived neurotrophic factor induced by transient forebrain ischemia in rats |
| Q39649446 | Expressions and possible roles of GDNF receptors in the developing dopaminergic neurons |
| Q33273600 | Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord |
| Q28591344 | Fate of midbrain dopaminergic neurons controlled by the engrailed genes |
| Q43916445 | Firing properties of axotomized central nervous system neurons recover after graft reinnervation. |
| Q37174039 | Frontiers in the surgical treatment of Parkinson's disease |
| Q42804521 | Functional characterization of an epidermal growth factor receptor/RET chimera |
| Q41190489 | Functional receptor for GDNF encoded by the c-ret proto-oncogene |
| Q24312738 | Functional recovery in parkinsonian monkeys treated with GDNF |
| Q40764405 | Functional regeneration in a rat Parkinson's model after intrastriatal grafts of glial cell line-derived neurotrophic factor and transforming growth factor beta1-expressing extra-adrenal chromaffin cells of the Zuckerkandl's organ. |
| Q40775860 | GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons |
| Q36414656 | GDNF and addiction |
| Q36906842 | GDNF delivery for Parkinson's disease. |
| Q90320680 | GDNF enhances human blood-nerve barrier function in vitro via MAPK signaling pathways |
| Q40963120 | GDNF family ligands and receptors are differentially regulated after brain insults in the rat. |
| Q41221025 | GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis |
| Q24658003 | GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse |
| Q40775287 | GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons |
| Q41065244 | GDNF is a trophic factor for adult rat corticospinal neurons and promotes their long-term survival after axotomy in vivo |
| Q41020374 | GDNF is abundant in the adult rat gut. |
| Q41290082 | GDNF is an age-specific survival factor for sensory and autonomic neurons |
| Q37462824 | GDNF is an endogenous negative regulator of ethanol-mediated reward and of ethanol consumption after a period of abstinence |
| Q40921870 | GDNF partially protects grafted fetal dopaminergic neurons against 6-hydroxydopamine neurotoxicity |
| Q40974397 | GDNF protection against 6-OHDA-induced reductions in potassium-evoked overflow of striatal dopamine. |
| Q41091623 | GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis. |
| Q41143148 | GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. |
| Q37392845 | GDNF secreted from adipose-derived stem cells stimulates VEGF-independent angiogenesis |
| Q41144843 | GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine. |
| Q41190484 | GDNF signalling through the Ret receptor tyrosine kinase |
| Q37203371 | GDNF therapy for Parkinson's disease |
| Q36928841 | GDNF--a potential target to treat addiction |
| Q28088320 | GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease |
| Q40954976 | GDNF: a novel factor with therapeutic potential for neurodegenerative disorders |
| Q40855279 | GFR alpha-1 is expressed in parvalbumin GABAergic neurons in the hippocampus |
| Q40763041 | GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area |
| Q24315709 | GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family |
| Q24649094 | GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney |
| Q64382253 | Gene therapy for Parkinson's disease |
| Q58767106 | Glial Cell Line-Derived Neurotrophic Factor (GDNF) Promotes Angiogenesis through the Demethylation of the Fibromodulin (FMOD) Promoter in Glioblastoma |
| Q39039257 | Glial Cell Line-Derived Neurotrophic Factor Family Members Reduce Microglial Activation via Inhibiting p38MAPKs-Mediated Inflammatory Responses |
| Q40904771 | Glial cell line derived neurotrophic factor promotes the recovery of dopamine neurons damaged by 6-hydroxydopamine in vitro |
| Q40676299 | Glial cell line neurotrophic factor-family receptor alpha-1 is present in central neurons with distinct phenotypes |
| Q34026231 | Glial cell line-derived neurotrophic factor (GDNF) as a defensive molecule for neurodegenerative disease: a tribute to the studies of antonia vernadakis on neuronal-glial interactions |
| Q41243427 | Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease |
| Q40972568 | Glial cell line-derived neurotrophic factor (GDNF) promotes the survival of axotomized retinal ganglion cells in adult rats: comparison to and combination with brain-derived neurotrophic factor (BDNF). |
| Q33939425 | Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion |
| Q31885989 | Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets |
| Q40666523 | Glial cell line-derived neurotrophic factor contributes to delayed inflammatory hyperalgesia in adjuvant rat pain model |
| Q34455675 | Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells |
| Q34349403 | Glial cell line-derived neurotrophic factor is crucial for long-term maintenance of the nigrostriatal system |
| Q40869470 | Glial cell line-derived neurotrophic factor modulates ischemia-induced tyrosine hydroxylase expression in rat hippocampus |
| Q39361781 | Glial cell line-derived neurotrophic factor promotes invasive behaviour in testicular seminoma cells. |
| Q33884388 | Glial cell line-derived neurotrophic factor promotes the survival and morphologic differentiation of Purkinje cells |
| Q41005670 | Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice |
| Q40961426 | Glial cell line-derived neurotrophic factor protects against delayed neuronal death after transient forebrain ischemia in rats |
| Q41108806 | Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex |
| Q40934563 | Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro |
| Q40935700 | Glial cell line-derived neurotrophic factor protects midbrain dopamine neurons from the lethal action of the weaver gene: a quantitative immunocytochemical study |
| Q40993667 | Glial cell line-derived neurotrophic factor requires transforming growth factor-beta for exerting its full neurotrophic potential on peripheral and CNS neurons. |
| Q40969225 | Glial cell line-derived neurotrophic factor rescues target-deprived sympathetic spinal cord neurons but requires transforming growth factor-beta as cofactor in vivo. |
| Q24311534 | Glial cell line-derived neurotrophic factor reverses ethanol-mediated increases in tyrosine hydroxylase immunoreactivity via altering the activity of heat shock protein 90 |
| Q40700434 | Glial cell line-derived neurotrophic factor up-regulates GTP-cyclohydrolase I activity and tetrahydrobiopterin levels in primary dopaminergic neurones |
| Q40875441 | Glial cell line-derived neurotrophic factor. Potential for otoprotection |
| Q39653262 | Glial cell line‐derived neurotrophic factor enhances in vitro differentiation of mid‐/hindbrain neural progenitor cells to dopaminergic‐like neurons |
| Q89138030 | Glial-derived neurotrophic factor is essential for blood-nerve barrier functional recovery in an experimental murine model of traumatic peripheral neuropathy |
| Q41033079 | Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats |
| Q40983994 | Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease. |
| Q48603966 | Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease. |
| Q36965800 | Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons |
| Q65589678 | History of Glial Cell Line-Derived Neurotrophic Factor (GDNF) and Its Use for Spinal Cord Injury Repair |
| Q39360374 | Human neural stem cells genetically modified to express human nerve growth factor (NGF) gene restore cognition in the mouse with ibotenic acid-induced cognitive dysfunction |
| Q39338787 | Human neural stem cells overexpressing choline acetyltransferase restore cognitive function of kainic acid-induced learning and memory deficit animals. |
| Q39833450 | Human neural stem cells overexpressing glial cell line-derived neurotrophic factor in experimental cerebral hemorrhage |
| Q40848213 | Immunohistochemical localization of glial cell line-derived neurotrophic factor in the human central nervous system |
| Q40675083 | Increase in secretion of glial cell line-derived neurotrophic factor from glial cell lines by inhibitors of vacuolar ATPase |
| Q46460358 | Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons |
| Q39926168 | Infusion of human umbilical cord blood cells ameliorates hind limb dysfunction in experimental spinal cord injury through anti-inflammatory, vasculogenic and neurotrophic mechanisms |
| Q40834975 | Injury induced c-Jun expression and phosphorylation in the dopaminergic nigral neurons of the rat: correlation with neuronal death and modulation by glial-cell-line-derived neurotrophic factor |
| Q40659852 | Interactions of cyclic adenosine monophosphate, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor treatment on the survival and growth of postnatal mesencephalic dopamine neurons in vitro |
| Q36281838 | Interactions of interleukin-1 with neurotrophic factors in the central nervous system: beneficial or detrimental? |
| Q41063070 | Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease. |
| Q48284526 | Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo |
| Q36561684 | Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. |
| Q37019997 | Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat |
| Q44306457 | Intravitreal injections of neurotrophic factors and forskolin enhance survival and axonal regeneration of axotomized beta ganglion cells in cat retina |
| Q40723341 | Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. |
| Q41053776 | Localization of glial cell line-derived neurotrophic factor receptor alpha and c-ret mRNA in rat central nervous system |
| Q40874496 | Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. |
| Q40675429 | Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system |
| Q48594084 | Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress |
| Q45178238 | Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model |
| Q88111994 | MicroRNAs in Parkinson's disease |
| Q36748675 | Midbrain dopamine neuron differentiation: factors and fates |
| Q38100525 | Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development. |
| Q44546945 | Mitogenic effect of glial cell line-derived neurotrophic factor is dependent on the activation of p70S6 kinase, but independent of the activation of ERK and up-regulation of Ret in SH-SY5Y cells |
| Q34657654 | Models of repair mechanisms for future treatment modalities of Parkinson's disease. |
| Q41132188 | Morphological alterations in the peripheral and central nervous systems of mice lacking glial cell line-derived neurotrophic factor (GDNF): immunohistochemical studies |
| Q33308730 | Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow |
| Q34075705 | M‐tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T‐tropic gp120 in rat striatum |
| Q36089698 | NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease |
| Q34999750 | Neurogenic maturation of human dental pulp stem cells following neurosphere generation induces morphological and electrophysiological characteristics of functional neurons |
| Q59051902 | Neuron saving schemes |
| Q41123196 | Neuronal GDNF expression in the adult rat nervous system identified by in situ hybridization |
| Q77977579 | Neuropathology and Virology of HIV Associated Dementia |
| Q40777710 | Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members |
| Q40776566 | Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. |
| Q33828029 | Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons |
| Q48291354 | Neurotoxins as Preclinical Models for Parkinson's Disease |
| Q35165435 | Neurotrophic factors for the investigation and treatment of movement disorders |
| Q37082060 | Neurotrophic factors for the treatment of Parkinson's disease. |
| Q36654492 | Neurotrophic factors in neurodegeneration. |
| Q48491947 | Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease |
| Q40875434 | Neurotrophic factors in the auditory periphery |
| Q41754674 | Neurotrophin-4/5 promotes dendritic outgrowth and calcium currents in cultured mesencephalic dopamine neurons |
| Q40653060 | Neurotrophins and their receptors in nerve injury and repair. |
| Q28274311 | Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons |
| Q40724503 | Neurturin is a neuritogenic but not a survival factor for developing and adult central noradrenergic neurons |
| Q40873179 | Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease |
| Q24324692 | Neurturin, a relative of glial-cell-line-derived neurotrophic factor |
| Q41671598 | Novel therapeutic directions for Parkinson's disease |
| Q50436779 | Optimized methods for rapidly dissecting spinal cords and harvesting spinal motor neurons with high survival and purity from rats at different embryonic stages |
| Q40532718 | Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system. |
| Q38930813 | Paracrine regulation of glioma cells invasion by astrocytes is mediated by glial-derived neurotrophic factor |
| Q34355457 | Parkinson disease: etiology, pathogenesis and future of gene therapy |
| Q26824184 | Parkinson's disease: gene therapies |
| Q35700596 | Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies. |
| Q46736932 | Pathological dynamics of activated microglia following medial forebrain bundle transection |
| Q37957125 | Pathways towards an effective immunotherapy for Parkinson's disease |
| Q38293728 | Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons |
| Q24315831 | Persephin, a novel neurotrophic factor related to GDNF and neurturin |
| Q37020931 | Pharmacological MRI (phMRI) monitoring of treatment in hemiparkinsonian rhesus monkeys |
| Q40590314 | Postischemic administration of Sendai virus vector carrying neurotrophic factor genes prevents delayed neuronal death in gerbils |
| Q41025144 | Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro |
| Q48096160 | Promoting neuroregeneration after perinatal arterial ischemic stroke: Neurotrophic factors and mesenchymal stem cells |
| Q34515354 | Prospects for the treatment of Parkinson's disease using neurotrophic factors |
| Q40958690 | Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle |
| Q40906953 | Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. |
| Q40081356 | Protection of dopaminergic neurons by electroconvulsive shock in an animal model of Parkinson's disease |
| Q36289043 | RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals. |
| Q40429860 | Radical directions in Parkinson's disease |
| Q38024220 | Recent preclinical evidence advancing cell therapy for Alzheimer's disease. |
| Q40706788 | Regulation of c-Ret, GFRalpha1, and GFRalpha2 in the substantia nigra pars compacta in a rat model of Parkinson's disease |
| Q40832131 | Regulation of glial cell line-derived neurotrophic factor responsiveness in developing rat sympathetic neurons by retinoic acid and bone morphogenetic protein-2. |
| Q28594756 | Renal agenesis and the absence of enteric neurons in mice lacking GDNF |
| Q28508969 | Renal and neuronal abnormalities in mice lacking GDNF |
| Q40839243 | Rescue of ischemic brain injury by adenoviral gene transfer of glial cell line-derived neurotrophic factor after transient global ischemia in gerbils |
| Q33964044 | Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult |
| Q39792829 | Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors |
| Q40310929 | Reversal of neurochemical changes and pain-related behavior in a model of neuropathic pain using modified lentiviral vectors expressing GDNF. |
| Q40959755 | Rho-dependent and -independent tyrosine phosphorylation of focal adhesion kinase, paxillin and p130Cas mediated by Ret kinase |
| Q35671426 | Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. |
| Q29391692 | Role of neurotrophic factors in neuronal development. |
| Q58693295 | Selected Metabolic Markers in Girls with Turner Syndrome: A Pilot Study |
| Q59064394 | Sensory but not motor neuron deficits in mice lacking NT4 and BDNF |
| Q48189155 | Serotonin hyperinnervation in the adult rat ventral mesencephalon following unilateral transection of the medial forebrain bundle. Correlation with reactive microglial and astroglial populations |
| Q41151008 | Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease |
| Q35842258 | Sorting protein-related receptor SorLA controls regulated secretion of glial cell line-derived neurotrophic factor |
| Q40307571 | Specific regulation of rat glial cell line-derived neurotrophic factor gene expression by riluzole in C6 glioma cells |
| Q41084332 | Specification and survival of dopaminergic neurons in the mammalian midbrain |
| Q34657608 | Stem cells in the treatment of Parkinson's disease. |
| Q39197001 | Striatal dopaminergic afferents concentrate in GDNF-positive patches during development and in developing intrastriatal striatal grafts. |
| Q40779553 | Stroke induces widespread changes of gene expression for glial cell line-derived neurotrophic factor family receptors in the adult rat brain |
| Q39641555 | Strong neurogenesis, angiogenesis, synaptogenesis, and antifibrosis of hepatocyte growth factor in rats brain after transient middle cerebral artery occlusion |
| Q81678822 | Surgical alleviation of Parkinson's disease |
| Q77110252 | Sustained delivery of GDNF: towards a treatment for Parkinson's disease |
| Q40699110 | TGFbeta induces GDNF responsiveness in neurons by recruitment of GFRalpha1 to the plasma membrane |
| Q41142426 | The GDNF-RET signalling partnership |
| Q41350370 | The RET proto-oncogene: a challenge to our understanding of disease pathogenesis |
| Q40243728 | The TAT protein transduction domain enhances the neuroprotective effect of glial-cell-line-derived neurotrophic factor after optic nerve transection |
| Q28591458 | The candidate neuroprotective agent artemin induces autonomic neural dysplasia without preventing peripheral nerve dysfunction |
| Q36709957 | The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies |
| Q40976248 | The effect of interferon-beta on mouse neural progenitor cell survival and differentiation |
| Q58558613 | The effects of exogenous human glial cell line-derived neurotrophic factor on functional regeneration of severed femoral nerve and its underlying mechanisms |
| Q47229270 | The high molecular weight fibroblast growth factor-2 isoforms (21,000 mol. wt and 23,000 mol. wt) mediate neurotrophic activity on rat embryonic mesencephalic dopaminergic neurons in vitro |
| Q34120740 | The primate model of Parkinson's disease: its usefulness, limitations, and importance in directing future studies |
| Q74697359 | The role of neuronal growth factors in neurodegenerative disorders of the human brain |
| Q42181057 | The role of neurotrophic factors conjugated to iron oxide nanoparticles in peripheral nerve regeneration: in vitro studies. |
| Q48797592 | The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra |
| Q32150534 | The weaver mutant mouse: a model to study the ontogeny of dopamine transmission systems and their role in drug addiction |
| Q33630577 | Therapeutic potential of nerve growth factors in Parkinson's disease |
| Q40715111 | Therapeutic time window of adenovirus-mediated GDNF gene transfer after transient middle cerebral artery occlusion in rat. |
| Q40802459 | Time dependent amelioration against ischemic brain damage by glial cell line-derived neurotrophic factor after transient middle cerebral artery occlusion in rat. |
| Q40760945 | Topographical localization of glial cell line-derived neurotrophic factor in the human brain stem: an immunohistochemical study of prenatal, neonatal and adult brains |
| Q40968259 | Toward trophic treatment in parkinsonism: a primate step |
| Q36802945 | Translational strategies in peripheral neuroinflammation and neurovascular repair |
| Q36532042 | Transplantation of Neural Stem Cells Cotreated with Thyroid Hormone and GDNF Gene Induces Neuroprotection in Rats of Chronic Experimental Allergic Encephalomyelitis |
| Q48242730 | Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats |
| Q40911934 | Transplantation of fetal kidney tissue reduces cerebral infarction induced by middle cerebral artery ligation |
| Q40731341 | Transplantation of germ cells from glial cell line-derived neurotrophic factor-overexpressing mice to host testes depleted of endogenous spermatogenesis by fractionated irradiation |
| Q37683979 | Transport of glial cell line-derived neurotrophic factor into liposomes across the blood-brain barrier: in vitro and in vivo studies |
| Q41264189 | Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-beta superfamily, on midbrain dopaminergic neurons |
| Q34240109 | Trophic factors and stem cells for promoting recovery in stroke. |
| Q38697393 | Trophic factors for Parkinson's disease: To live or let die. |
| Q40232814 | Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. |
| Q40688756 | XIB4035, a novel nonpeptidyl small molecule agonist for GFRalpha-1. |
| Q48238293 | Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson's disease |
| Q33949411 | c-Jun mediates axotomy-induced dopamine neuron death in vivo |
Search more.